Abstract:Objective To explore hypermethylation of RARβ2, GSTP1 and DAPK gene in prostate cancer tissues, and to explore its correlation with clinicopathological features of prostate cancer and its diagnostic value. Methods Hypermethylation of RARe2, GSTP1 and DAPK gene was detected by nested methylation-specific PCR (NMSP) in 57 prostate cancer (PCa) tissues and 35 benign prostate hyperplasia (BPH) tissues. The correlation between hypermethylation and clinicopathological features of prostate cancer and its diagnostic value were analyzed. Results The hypermethylation frequencies of RARβ2, GSTP1 and DAPK gene in PCa were significantly higher than those in BPH (RARβ2: 52.6% vs. 0% GSTP1: 61.4% vs. 2.9%;DAPK: 43.9% vs. 8.6%;all P<0.01). The methylation rate of RARβ2 gene was directly correlated with distinct Gleason scores and clinical stage (4～7 score vs. 8～10 score: 34.8% vs. 64.7%;stage B, C vs. stage D: 37.0% vs. 66.7%;x2=4.927 and 5.004, P=0.026 and 0.025). The methylation rate of GSTP1 gene was significantly different in patients with different Gleason scores (4～7 score vs. 8～10 score: 43.5% vs. 73.5%;x2 =11.530, P=0.001), but had no difference in patients with distinct clinical stage (stage B, C vs. stage D: 51.9% vs. 70.0%;x2=1.975, P=0.16) . There was no difference in DAPK gene methylation rate among patients with different Gleason scores and distinct clinical stage (4 ～7 score vs. 8～10 score: 39.1% vs. 50.0%;stage B, C vs. stage D: 33.3% vs. 53.3%;x2= 1.290 and 2.309, both P～0.05). GSTP1 gene showed the highest sensitivity of 61.4% (35/57)with specificity of 97.1%(34/35), while RARβ2 gene had the highest specificity of 100% (35/35) with the sensitivity of 52.6% (30/57). The sensitivity and specificity of DAPK gene were 43.9% and 91.4% (25/57 and 32/35), respeetively. When the hypermethylation of RARβ2, GSTP1 and DAPK gene were detected together, the diagnostic sensitivity was increased, but the specificity was decreased. Conclusions The aberrant methylation of RARβ2, GSTP1 and DAPK gene is correlated with tumorigenesis and progression of prostate cancer, which may be used as an effective diagnostic marker for prostate cancer.

The Promoter Hypermethylation of DAPK Gene and P16 Gene in Non-Small Cell Lung Cancer Patients

Detection of aberrant methylation of RARβ2, GSTP1 and DAPK gene in prostate cancer and its clinical significance

Hypermethylation of GSTP1 and DAPK gene in prostate cancer

Analysis of Promoter Hypermethylation of P16 Gene in Sera from Non-Small Cell Lung Cancer Patients

Association of Abnormal Methylation of CpG Islands in Promoter Domains of Multiple Tumor Suppressor Genes with Non-Small Cell Lung Cancer

Analysis of Promoter Hypermethylation of Death-Asscciated Protein Kinase Gene in Blood from Non-Small Cell Lung Cancer Patients

Detection of Promoter Hypermethlation of DAPK Gene in Sera from Non-small Cell Lung Cancer Patients by Modified MSP

Association Between P16INK4a Promoter Methylation and Non-Small Cell Lung Cancer: A Meta-Analysis

Promoter Hypermethylation of P16 Gene and DAPK Gene in Sera from Hepatocellular Carcinoma (HCC) Patients

Analysis of RASSF1A promoter hypermethylation in serum DNA of non-small cell lung cancer patients

Death-associated protein kinase promoter methylation correlates with clinicopathological and prognostic features in nonsmall cell lung cancer patients: A cohort study.

Detection of p16 hypermethylation in circulating plasma DNA of non-small cell lung cancer patients.

Clinical Analysis of Methylation of p16 Gene in Non-small Cell Lung Cancer

Methylation of P 16 and RASSF 1A Genes in Sputum Samples Associated with Peripheral Non-Small Cell Lung Cancer

A Novel Method of Microarray Quantitave Analysis of P16 CPG Island Methylation in Leukemia Cells from Patients with Hematological Malignancies.

Aberrant Hypermethylation at Sites -86 to 226 of DAB2 Gene in Non-Small Cell Lung Cancer

Association of Promoter Methylation with Histologic Type and Pleural Indentation in Non-Small Cell Lung Cancer (NSCLC)

Quantitative Assessment of Gene Promoter Methylation in Non-Small Cell Lung Cancer Using Methylation-Sensitive High-Resolution Melting.

Detection of P16 Gene Methylation by Methylation-Specific PCR and Its Clinical Significance in Lung Cancer

The Prognostic Value Of P16 Hypermethylation In Cancer: A Meta-Analysis

Correlation between methylation status of tumor-related genes and mRNA transcriptional level in lung cancer cell lines.